[Company Logo Image]

















 

BioDefense and Homeland Security: Opportunities for Biotechnology Companies 2006  written by BioAbility®
 
All eyes are on the biotechnology industry and biotechnology research centers to contribute to the effort for biodefense.  The U.S. Government is spending billions of dollars on this effort.  U.S. companies, universities, and other research institutions are encouraged to work on these projects.
This biodefense resource guide is designed to help steer biotechnology, pharmaceutical, and med-tech companies through the labyrinth of opportunities, programs and procedures in the emerging biodefense industry.

Most beneficial from this report are the profiled success stories of companies that have developed a successful niche in biodefense. By examining how these companies have gotten their foot in the door and have gone on to flourish, we're able to provide you a roadmap to hopefully do the same.

96 success stories from 75 companies and institutes are provided. Examples include:
bulletAcambis Inc.
bulletAdvanced Biosystems Inc.
bulletArizona State University
bulletDana-Farber Cancer Institute
bulletEluSys Therapeutics Inc.
bulletHawaii Biotech Inc.
bulletHemoCleanse Inc.
bulletIsis Pharmaceuticals Inc.
bulletMicroFluidic Systems Inc.
bulletNanoBio Corp.
bulletNortheast Biodefense Center
bulletOmrix Biopharmaceuticals S.A.
Take advantage of grants and funding programs by knowing who to contact!

Biodefense and Homeland Security: Opportunities for Life Sciences Companies 2006 pinpoints where and how to obtain funding, and explains how to contact the proper officials in charge of specific granting programs. It not only identifies the agencies and groups that have an interest in biotechnology and med-tech solutions, but it also acts as a useful tool in providing insight into future developments.

Key contacts listed at U.S. federal agencies:
bulletDHS
bulletNIH/NIAID
bulletDOD
bulletDOA
bulletNIST
bulletUSDA
bulletEPA
bulletHHS
bulletFDA
bulletCDC
bulletDOE
Many federal agencies are expanding biodefense initiatives that will require expertise from a variety of scientific and technology industries. This report has a broad scope to cover and provide an understanding of these newly announced programs and areas of special interest.

Details on biodefense programs by research area include:
bulletDrugs & vaccines
bulletPlant agriculture
bulletAgrochemicals
bulletEnzymes & chemicals
bulletBiomaterials
bulletAnimal agriculture
bulletDiagnostics

To order, contact BioAbility® at 919.544.5111 or info@bioability.com or BioWorld Today (www.BioWorld.com).

 

 

 

 
 

Send mail to info@bioability.com with questions or comments about this web site.
Copyright © 2008  BioAbility   BioAbility
® is a registered servicemark of BioAbility, LLC.
Last modified: May 22, 2008